Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does lead to some loss of lean mass alongside fat, as almost every calorie-deficit intervention does — but the evidence suggests that meaningful muscle protection is possible with the right approach. In clinical trials, the majority of weight lost on tirzepatide was fat mass. Protein intake and resistance activity play the largest role in preserving what you've built. Mounjaro is a prescription-only medicine, and a prescriber will assess whether it is suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you've searched this question, you're probably already making gains in the gym, or you're worried about coming out of treatment looking and feeling weaker. That concern is entirely reasonable, and it deserves a straight answer rather than reassurance that glosses over the biology.
Any sustained calorie deficit causes the body to draw energy from multiple sources. Fat stores are the primary target, but lean tissue is also broken down, especially when protein intake is low or physical activity drops. This is not unique to Mounjaro. It happens with conventional dieting, bariatric surgery, and every GLP-1 treatment studied so far.
In the SURMOUNT-1 trial (the landmark study of tirzepatide for weight management involving around 2,500 adults, published in the New England Journal of Medicine) participants lost an average of roughly 20% of their body weight at the highest dose. Researchers measured body composition, and the data showed that the large majority of weight lost was fat mass. Lean-mass loss occurred, but proportionately less than the fat loss. So Mounjaro does not appear to be unusually muscle-depleting compared with other methods that produce equivalent weight loss.
The honest summary: yes, some lean-mass reduction is likely during tirzepatide treatment; no, it is not the dominant effect; and yes, it is substantially modifiable by what you eat and how you move.
Two mechanisms matter most. First, the calorie deficit itself. When energy intake falls sharply, the body increases protein turnover, and muscle is not immune. Second, appetite suppression. Mounjaro reduces hunger significantly by acting on both GIP and GLP-1 receptors, slowing gastric emptying and signalling fullness to the brain. The result is that many people eat far less overall (which is the treatment working as intended) but also eat far less protein, which accelerates lean-mass losses.
There is a third, underappreciated factor: spontaneous physical activity tends to fall when people are eating much less and losing weight rapidly. Fewer calories available means less energy for day-to-day movement, and muscle fibres that are not regularly loaded will atrophy over time regardless of the treatment involved.
None of this means treatment should be avoided. It means treatment works best when paired with deliberate protein targets and structured resistance exercise. The NHS tirzepatide page notes that the medicine is licensed for use alongside a reduced-calorie diet and increased physical activity, precisely because lifestyle components are not optional additions, they are part of how the medicine is designed to be used.
There is no single agreed figure, but the broad consensus in sports nutrition and clinical dietetics sits between 1.2 g and 1.6 g of protein per kilogram of body weight per day during active weight loss. At higher rates of loss, some researchers recommend closer to 2 g/kg. Population averages of around 2,000 kcal for women and 2,500 kcal for men are rough reference points only; your actual requirements depend on starting weight, activity level, and how quickly you're losing.
The practical challenge is that Mounjaro reduces appetite enough that hitting even modest protein targets can feel like a task. Prioritising protein at each meal (before fats and carbohydrates) is the most consistently useful strategy. Greek yoghurt, eggs, white fish, chicken breast, cottage cheese and legumes all offer high protein-to-calorie ratios. For a full breakdown of meal choices on treatment, the eating guide for Mounjaro covers practical approaches in detail.
It is worth discussing your protein targets with a dietitian or your prescriber, especially if your appetite suppression is severe. A prescriber can also review whether your titration pace is appropriate for your lifestyle and lean-mass goals. For information on how much the private prescription route costs and what is included, the Mounjaro price comparison page sets out the context clearly.
Yes. Resistance training is the single most evidence-backed intervention for preserving lean mass during weight loss, and that holds on GLP-1 treatment specifically. Muscles that are regularly challenged with load get a biochemical signal to maintain (and in some cases grow) even in a calorie deficit. Two sessions a week is enough to produce a measurable effect; three or more is better if your energy allows.
You do not need to lift heavy. Bodyweight exercises, resistance bands, and moderate machine or free-weight work all count. The key variable is progressive overload over time: gradually increasing reps, resistance, or difficulty so the muscle continues to receive a challenge. Cardio-only exercise, though excellent for cardiovascular health and calorie expenditure, provides a weaker signal for muscle retention.
There are other side effects worth being aware of during treatment, and if you have found yourself wondering whether Mounjaro makes you sweat more than usual, you are not alone, as this is something a number of people on treatment report and it can affect comfort during exercise. These are usually manageable and rarely a reason to avoid activity. The broader treatment overview on our Mounjaro page covers the clinical picture in full. If you want to explore whether treatment is right for you, checking your eligibility is the first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.